Reflections as we prepare for the Jewish New Year
An Open Letter from Uzi Sofer, Alpha Tau’s CEO Dear Alpha Tau Team, As we prepare to welcome the Jewish New Year, I want to pause and reflect with you on the journey that we have made over the past year. Thank God, it has been an extraordinary year for Alpha Tau. Many years of […]
לקראת סיומה של שנת תשפ״ו וכניסתה של שנת תשפ״ז
מכתב מעוזי סופר, מנכ”ל אלפא תאו, לסיומה של שנת תשפ״ו וכניסתה של שנת תשפ״ז עובדות ועובדי אלפא תאו היקרים, לקראת סיומה של שנת תשפ״ו וכניסתה של שנת תשפ״ז, אני רוצה לעצור לרגע ולהביט יחד אתכם על הדרך שעשינו בשנה האחרונה. ברוך השם זו הייתה שנה יוצאת דופן עבור אלפא תאו. שנה שבה שנים של מחקר, […]
Five Takeaways from AHNS 2026: Alpha DaRT in Combination with Immunotherapy for Advanced Head and Neck Cancer
A Conversation with Prof. Aron Popovtzer, MD Prof. Aron Popovtzer, MD Chair, Sharett Institute of Oncology, and Co-Chair, Hadassah Cancer Research Institute Hadassah University Medical Center, Jerusalem With Gideon D. Matthews PhD, Commercial VP, Alpha Tau Medical Introduction Every year, roughly 890,000 people around the world are told they have a cancer of the mouth, […]
Re-examining Liver Tumor Response with Intratumoral Alpha Radiotherapeutics – A Three-Way Conversation on a Landmark New Preclinical Study in Colorectal Liver Metastases
With Gideon D. Matthews PhD, Commercial VP, Alpha Tau Medical Introduction There are moments in science when a paper lands and you sense, before the data has been widely read, that a new frontier may perhaps be opened in the field of cancer research. The study published this week in Scientific Reports is one of […]
Alpha DaRT® and Checkpoint Inhibitors: Igniting the Immune System for a Cancer Care Breakthrough
By Dr. Robert Den MD and Dr. Vered Domankevich PhD Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) is a novel intratumoral radiotherapeutic technology that not only seeks to destroy tumors locally but also may trigger powerful immune system activation. By implanting tiny Radium-224 sources directly into a tumor, clinicians use Alpha DaRT to deliver high-energy alpha […]
Interview with Dr. Mark D’Andrea – Understanding Pancreatic Cancer
Understanding Pancreatic Cancer Receiving a diagnosis of pancreatic cancer can be devastating, and all too often it arrives at a stage where surgical removal is no longer an option. This is because pancreatic cancer is frequently silent until it progresses; by the time symptoms appear, the disease has often spread beyond the pancreas. Yet, despite […]
Interview with Dr. Harold Jacob on Alpha DaRT for Pancreatic Cancer
Dr. Harold Jacob Director of Advanced Gastrointestinal Endoscopy Hadassah University Medical Center Alpha TAU Medical VP Marketing Gideon Matthews, PhD recently sat with Dr. Harold Jacob, Director of Gastrointestinal Endoscopy, Hadassah University Medical Center, to discuss currently ongoing clinical trials of the Alpha DaRT® for the treatment of pancreatic cancer at Hadassah. You have many […]
Alpha DaRT Investigator Meeting in Las Vegas
Coming Up Soon – Alpha DaRT Investigator Meeting in Las Vegas Alpha Tau is pleased to announce that the Alpha DaRT Investigator Meeting, for investigators participating in the US Multicenter Pivotal Study for Skin Cancer, will be held in Las Vegas Nevada, February 27-28. We look forward to seeing our clinical collaborators at The Venetian […]
Lela’s Story of her Cancer Treatment Journey that Brought her to Alpha DaRT
Introduction When 78-year-old Israeli cancer patient Lela Parnes stumbled upon the Alpha DaRT treatment in 2017, with information from a friend of hers, she had just received her third diagnosis of cancer in multiple organs, as part of a long journey that had started in 2013. Lela’s Cancer Treatment Journey Lela had first been diagnosed […]
Alpha-emitting Radiation Therapy Could Create a Paradigm Shift in Cancer Treatment
As the new Chief Medical Officer of Alpha Tau Medical, I passionately believe that the success of our new alpha-emitting radiation therapy, Alpha DaRT, has the potential to create a paradigm shift in cancer care. Despite advances in conventional therapies, there are still many patients who succumb to their disease or who are unable to […]